Researchers at Oregon Health & Science University have developed the first transgenic nonhuman primate model—genetically ...

A consultant Public Health Physician at Ikorodu General Hospital, Dr Yetunde Odusolu has called for an urgent action to prevent hepatitis, ...

Feb. 5, 2025 — Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful ...

Gonorrhoea is being flagged as an STD that spreads through unprotected sex. Women may encounter symptoms such as vaginal ...

The viral illness kills more people in the city than HIV, but antiviral medications may be helping cut its transmission.

GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...

What you need to know ### BMJ Learning To obtain accredited continuous professional development points, subscribers to BMJ Learning can complete the full module at The module contains seven ...

Viral hepatitis is a major danger to public health. According to WHO’s 2024 Global Hepatitis Report, viral hepatitis deaths ...

Discover a clinical trial that was conducted to evaluate the efficacy and safety of autologous HBV vaccine-pulsed dendritic cells and their induced T cells.

Pharmaceutical giant GSK and the University of Oxford are collaborating on developing a cancer vaccine that aims to detect pre-cancer cells up to 20 years before they become malignant. This ...

The mRNA technology behind the Pfizer and Moderna vaccines are groundbreaking, but their potential goes way beyond COVID-19. They have the ability to help the body fight a multitude of diseases ...